Early Access — free while we kick the tires
EdgarHawk

Fortney Kristen

Chief Executive Officer

Director Officer
1 filing analyzed · 1 company · Latest 2026-01-15

Companies

Company Buys Sells Direction
BioAge Labs, Inc. BIOA 0 1 Net selling

Activity

January 2026
2026-01-15 BioAge Labs, Inc. BIOA
high
Sell
233,107 shares
$4,223,036
Significance 7/10

CEO Fortney Kristen sells 233,107 shares of BIOA at $18.12 for $4.2M; retains 976,949 shares amid unprofitable operations.

Kristen, as Chief Executive Officer, sold 233,107 shares at $18.12, reducing her holdings by 19.3% from 1.21M to 976.9K shares. The company reported negative net income of $-20.2M against quarterly revenue of $2.1M, indicating ongoing unprofitability. The transaction occurred at $18.12, trading 6.2% below the 52-week high of $22.92, despite a sharp 71.9% gain over the prior 30 days and 315.2% surge over 90 days. The combination of substantial insider share reduction during a period of significant recent price appreciation, concurrent with documented operating losses, merits close attention to whether this disposal reflects capital-raising requirements or reflects management's assessment of near-term value relative to longer-term fundamentals.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access